187 related articles for article (PubMed ID: 18549922)
1. The year in interventional cardiology.
Dixon SR; Grines CL; O'Neill WW
J Am Coll Cardiol; 2008 Jun; 51(24):2355-69. PubMed ID: 18549922
[No Abstract] [Full Text] [Related]
2. [Interview with Prof. Franz-Joseph Krozingen: Interventional cardiology on the success course].
Neumann FJ
MMW Fortschr Med; 2010 Apr; 152(13):18. PubMed ID: 20443337
[No Abstract] [Full Text] [Related]
3. Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely.
Chhatriwalla AK; Bhatt DL
Circ Cardiovasc Interv; 2008 Dec; 1(3):217-25. PubMed ID: 20031681
[No Abstract] [Full Text] [Related]
4. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
Spinler SA
Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A;
J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982
[TBL] [Abstract][Full Text] [Related]
6. Target lesion revascularization after bare-metal or drug-eluting stents: clinical presentation and outcomes.
Vidi VD; Arora N
J Invasive Cardiol; 2010 Jun; 22(6):271-2. PubMed ID: 20516506
[No Abstract] [Full Text] [Related]
7. Late outcomes after drug-eluting stent implantation in "real-world" clinical practice.
Ramsdale DR; Rao A; Asghar O; Ramsdale KA; McKay E
J Invasive Cardiol; 2008 Oct; 20(10):493-500. PubMed ID: 18829991
[TBL] [Abstract][Full Text] [Related]
8. 2007 focused update to the ACC/AHA guidelines for the management of patients with ST-segment elevation myocardial infarction: implications for emergency department practice.
Pollack CV; Antman EM; Hollander JE; ;
Ann Emerg Med; 2008 Oct; 52(4):344-355.e1. PubMed ID: 18519158
[TBL] [Abstract][Full Text] [Related]
9. [Acute coronary syndrome -- long term protection by dual thrombocyte aggregation inhibition during twelve months].
MMW Fortschr Med; 2008 Oct; 150(42):52-3. PubMed ID: 18983063
[No Abstract] [Full Text] [Related]
10. [Cardiology 2007].
Hoppe UC; Erdmann E
Dtsch Med Wochenschr; 2007 Jun; 132(25-26):1365-7. PubMed ID: 17570081
[No Abstract] [Full Text] [Related]
11. Clopidogrel use in diabetic patients with new stents.
Cardiovasc J Afr; 2008; 19(4):232. PubMed ID: 18776976
[No Abstract] [Full Text] [Related]
12. Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction.
Lee CW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Yun SC; Seong IW; Lee JH; Lee NH; Cho YH; Cheong SS; Lim DS; Yang JY; Lee SG; Kim KS; Yoon J; Jeong MH; Seung KB; Hong TJ; Park SJ;
Am J Cardiol; 2009 Nov; 104(10):1370-6. PubMed ID: 19892052
[TBL] [Abstract][Full Text] [Related]
13. Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Alfonso F; Pérez-Vizcayno MJ; Hernández R; Bethencourt A; Martí V; López-Mínguez JR; Angel J; Iñiguez A; Morís C; Cequier A; Sabaté M; Escaned J; Jiménez-Quevedo P; Bañuelos C; Suárez A; Macaya C;
J Am Coll Cardiol; 2008 Nov; 52(20):1621-7. PubMed ID: 18992651
[TBL] [Abstract][Full Text] [Related]
14. Clopidogrel response variability and future therapies: clopidogrel: does one size fit all?
O'Donoghue M; Wiviott SD
Circulation; 2006 Nov; 114(22):e600-6. PubMed ID: 17130347
[No Abstract] [Full Text] [Related]
15. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
[TBL] [Abstract][Full Text] [Related]
16. Aspirin + clopidogrel therapy: how does your care compare to the evidence?
Simmons BB; Salzman BE
J Fam Pract; 2008 Jan; 57(1):26-32. PubMed ID: 18171566
[No Abstract] [Full Text] [Related]
17. The year in non-ST-segment elevation acute coronary syndromes.
Giugliano RP; Braunwald E
J Am Coll Cardiol; 2006 Jul; 48(2):386-95. PubMed ID: 16843191
[No Abstract] [Full Text] [Related]
18. Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction.
Morrow DA; Wiviott SD; White HD; Nicolau JC; Bramucci E; Murphy SA; Bonaca MP; Ruff CT; Scirica BM; McCabe CH; Antman EM; Braunwald E
Circulation; 2009 Jun; 119(21):2758-64. PubMed ID: 19451347
[TBL] [Abstract][Full Text] [Related]
19. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
20. Successful clopidogrel desensitization after drug-eluting stent implantation.
Kammer RT
J Invasive Cardiol; 2009 Mar; 21(3):134-5. PubMed ID: 19258645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
